Pregabalin (Lyzalon)
What to know about Pregabalin — also sold as Lyzalon, Pregabalin Sandoz, APO-Pregabalin, PREGABALIN-DRLA, Neuroccord and 5 more: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Pregabalin (brand names: Lyzalon, Pregabalin Sandoz, APO-Pregabalin, PREGABALIN-DRLA, Neuroccord and 5 more) is classified as Moderate risk (3 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Gabapentinoid with significant CNS depression, abuse potential, and dangerous synergy with other depressants.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Moderate (3 points)
- CNS depressant: May cause sedation, impair driving, and affect work capacity
- Recommended maximum duration: 90 days
- SIRA reportable: Flagged for NSW workers compensation reporting
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
Risk Profile
Gabapentinoid with significant CNS depression, abuse potential, and dangerous synergy with other depressants.
How Pregabalin is regulated
Pregabalin is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Work capacity impact: As a CNS depressant, Pregabalin may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Flagged as reportable under SIRA guidelines in NSW. Claims involving this medication may require additional reporting and clinical justification.
United Kingdom NICE / MHRA / FPM
NICE CG173 (Neuropathic Pain) includes pregabalin and gabapentin as treatment options for neuropathic pain. The MHRA has issued safety warnings about gabapentinoid misuse and respiratory depression risk when combined with opioids.
UK drug driving laws (Section 5A Road Traffic Act 2006) set specific limits for prescription drugs that cause impairment. Employers and occupational health advisors should assess fitness to work.
Check this medication against your full medication list
Run a full risk assessment including Pregabalin interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.